Julianne Hibbs, D.O. is board-certified in Internal Medicine and specializes in Oncology/Hematology. Dr. Hibbs received her medical degree from Philadelphia College of Osteopathic Medicine and completed an Internal Medicine residency and internship at Pennsylvania Hospital. She completed her fellowship in Hematology and Oncology at Lankenau Hospital. Dr. Hibbs is a member of the American Board of Internal Medicine.

Lorraine Dougherty, M.D., completed her Hematology and Oncology fellowship at Fox Chase Cancer Center. Dr. Dougherty received her medical degree from the University of Pennsylvania School of Medicine, where she also concluded her Internal Medicine internship and residency. Dr. Dougherty is a current member of the American Society of Clinical Oncology.

James L. Spears, M.D., completed his fellowship in Hematology and Oncology at Lankenau Hospital. Dr. Spears obtained his medical degree from Case Western Reserve University School of Medicine in Cleveland. Dr. Spears completed his Internal Medicine internship and residency at Georgetown University Hospital. Dr. Spears is an active member of the American Society of Clinical Oncology and American Medical Association.

Howard Zipin, MD, completed his fellowship in Hematology and Oncology at Fox Chase Cancer Center. Dr. Zipin obtained his medical degree from Temple University School of Medicine, where he completed his Internal Medicine internship and residency. Dr. Zipin is the Medical Director of the Cancer Care Program at Abington Health Lansdale Hospital. Dr. Zipin is a member of the American Society of Hematology, American Society of Clinical Oncology, and American Medical Association.

Mitchell Alden, DO completed his fellowship in Hematology and Oncology at Fox Chase Cancer Center. Dr. Alden received his medical degree from the Philadelphia College of Osteopathic Medicine. Dr. Alden completed his Internal Medicine residency at Cooper University Medical Center in Camden New Jersey and his internship at Suncoast Hospital in Clearwater Florida. Dr. Alden is the Director of the Doylestown Hospital Cancer Program. He is currently a member of the American Society of Cancer Research and the American Society of Clinical Oncology.

Anthony Magdalinski, III, D.O., completed his fellowship in Hematology and Oncology at Hahnemann University Hospital. Dr. Magdalinksi obtained his medical degree from the Philadelphia College of Osteopathic Medicine. He completed his Internal Medicine residency with Episcopal Hospital and his internship at West Allegheny Osteopathic Hospital. Dr. Magdalinski has more than 20 years of experience in progressive oncology treatment with special expertise in cancers of the blood.